When Should Progression Lead to Treatment Changes? – 2022 Program: Targeted Therapies Forum Non-Small Cell Lung Cancer 1 Min Read0 Understanding when to adjust cancer treatment is paramount in patient care. In this crucial session, Drs. Desai, Khalil, and Luo…
Belzutifan, Androgen Receptor Degraders, and Antibody Drug Conjugates Genitourinary 4 Mins Read15 Novel Therapies for Patients with Genetourinary Malignancies By: Rana R. McKay, MD – Medical Oncologist University of California San…
Urothelial Cancer: What’s New in 2023? [Slides] Targeted and Novel Therapies Nataliya Mar MD Bladder 16 Mins Read1 Urothelial Cancer: What’s New in 2023? Targeted and Novel Therapies Nataliya Mar MD By Nataliya Mar, MD Good afternoon, everyone.…
